Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
5% from Cmax/request from MoH RF 5% from Cmax/request from MoH RF "minimal average"??	Beholder	2016-05-23 16:23	2	2016-05-23 15:28	4,937
hidden pill ? Let's reconnect with the real world, please Let's reconnect with the real world, please Let's reconnect with the real world, please Relax! Relax! Relax! Relax! Let's reconnect with the real world, please Let's reconnect with the real world, please Let's reconnect with the real world, please hidden pill ? hidden pill ?	Scientist fellow	2016-06-19 08:59	12	2016-07-06 12:24	10,093
How to understand what is guilty? How to understand what is guilty? How to understand what is guilty? How to understand what is guilty? Post-hoc power is useless! Post-hoc power is useless! Post-hoc power is useless! Post-hoc power is useless! Post-hoc power is useless! Post-hoc power is useless!	BE-proff	2016-07-30 18:21	9	2016-08-09 14:17	9,567
Bayesian BE Assessment Bayesian BE Assessment	Ben	2017-03-13 18:55	1	2017-03-14 10:45	3,633
Vasoconstriction Study	Research Scientist	2017-05-20 11:36	0		2,169
Study Results Study Results upper CL < PE PE restriction for HVDs/HVDPs; testing effects PE restriction for HVDs/HVDPs; testing effects PE restriction for HVDs/HVDPs; testing effects PE restriction for HVDs/HVDPs; testing effects PE restriction for HVDs/HVDPs GMR outside the limits when using ABEL Regulations ≠ Science Regulations ≠ Science	VSL	2015-04-20 21:46	10	2017-05-22 18:51	14,620
Pivotal and pilot BE Study Pivotal and pilot BE Study Pivotal and pilot BE Study Pivotal and pilot BE Study Pivotal and pilot BE Study Retained samples?	K Vishal	2017-07-07 11:17	5	2017-07-08 15:01	11,665
EU ombudsman looking into EMA presubmission meetings EU ombudsman looking into EMA presubmission meetings EU ombudsman looking into EMA presubmission meetings EU ombudsman looking into EMA presubmission meetings	ElMaestro	2017-07-19 20:24	3	2017-07-20 08:12	6,414
Atorvastatin intra-subject Variability Atorvastatin intra-subject Variability Atorvastatin intra-subject Variability Atorvastatin intra-subject Variability	Amira	2017-09-26 12:26	3	2017-09-27 09:05	7,684
AUC infinity AUC infinity: primary for the FDA AUC infinity: primary for the FDA AUC infinity: primary for the FDA	mokhtar saleh	2017-10-24 16:58	3	2017-10-27 03:42	7,487
ULOQ ULOQ ULOQ ULOQ ULOQ Not excluding invalid data? Excluding invalid data ULOQ Serial dilutions? Don’t!	Anand	2017-10-30 06:38	8	2017-10-30 17:03	10,545
risk management	Norah	2018-01-22 13:53	0		2,445
Ever handled the "wrong treatment" in a PK?	Relaxation	2018-01-26 18:31	0		2,857
When the the infusion speed deviate from the protocol specified Different PK profile Different PK profile Different PK profile Different PK profile Suitable equipment? Suitable equipment? AUC=f·D/CL AUC=f·D/CL AUC=f·D/CL AUC=f·D/CL When the the infusion speed deviate from the protocol specified When the the infusion speed deviate from the protocol specified	ssussu	2018-02-06 10:48	12	2018-02-08 23:31	11,926
Outlier in BE Low AUC after reference product Low AUC after reference product Outlier in BE Outlier in BE Outlier in BE	ramgopi	2018-03-14 11:29	5	2018-03-19 09:55	7,125